Concepedia

Junshan Qiu

JQ

Statistics

Publications

14

Citations

951

H-Index

12

Active since

1998

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Chinese Academy of Sciences

Center for Devices and Radiological Health

University of Shanghai for Science and Technology

Junshan Qiu is an author at Center for Drug Evaluation and Research specializing in clinical trials, statistics, and medicine.

ORCID

Top concepts

Publications per year

1998–2023

14

Publications

14

FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer

Preeti Narayan, Tatiana M. Prowell, Jennifer Gao et al. · Clinical Cancer Research · 2020 · 157 citations · Full text

FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer

Preeti Narayan, Christy Osgood, Harpreet Singh et al. · Clinical Cancer Research · 2021 · 155 citations · Full text

FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Donna Przepiorka, Lola Luo, Sriram Subramaniam et al. · The Oncologist · 2019 · 129 citations · Full text

, , +17

Multilaboratory Survey To Evaluate Salmonella Prevalence in Diarrheic and Nondiarrheic Dogs and Cats in the United States between 2012 and 2014

Renate Reimschuessel, Michael Grabenstein, Jake Guag et al. · Journal of Clinical Microbiology · 2017 · 102 citations · Full text

FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer

Asma Dilawari, Mirat Shah, Gwynn Ison et al. · Clinical Cancer Research · 2023 · 93 citations · Full text

Rows per page

1–5 of 14